======= CACYBP =======
== Gene Information ==
* **Official Symbol**: CACYBP
* **Official Name**: calcyclin binding protein
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=27101|27101]]
* **UniProt**: [[https://www.uniprot.org/uniprot/Q9HB71|Q9HB71]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=CACYBP&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20CACYBP|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/606186|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: The protein encoded by this gene is a calcyclin binding protein. It may be involved in calcium-dependent ubiquitination and subsequent proteosomal degradation of target proteins. It probably serves as a molecular bridge in ubiquitin E3 complexes and participates in the ubiquitin-mediated degradation of beta-catenin. Two alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008].
* **UniProt Summary**: May be involved in calcium-dependent ubiquitination and subsequent proteasomal degradation of target proteins. Probably serves as a molecular bridge in ubiquitin E3 complexes. Participates in the ubiquitin-mediated degradation of beta-catenin (CTNNB1). {ECO:0000269|PubMed:16085652}.
|CS|
|Siah-Interact N|
|SGS|
|nuclear envelope lumen|
|beta-catenin destruction complex|
|S100 protein binding|
|response to growth hormone|
|positive regulation of DNA replication|
|tubulin binding|
|SCF ubiquitin ligase complex|
|cell body|
|cellular response to calcium ion|
|cardiac muscle cell differentiation|
|response to leukemia inhibitory factor|
|cellular response to leukemia inhibitory factor|
|regulation of DNA replication|
|cardiocyte differentiation|
|response to calcium ion|
|cardiac muscle tissue development|
|cellular response to metal ion|
|striated muscle cell differentiation|
|cellular response to inorganic substance|
|protein domain specific binding|
|muscle cell differentiation|
|aging|
|striated muscle tissue development|
|ubiquitin protein ligase binding|
|muscle tissue development|
|neuron projection|
|response to metal ion|
|response to peptide hormone|
|response to peptide|
|muscle structure development|
|heart development|
|response to inorganic substance|
|circulatory system development|
|protein homodimerization activity|
|response to hormone|
|negative regulation of cell death|
|response to organonitrogen compound|
|cellular response to cytokine stimulus|
|response to nitrogen compound|
|response to cytokine|
|response to endogenous stimulus|
|response to oxygen-containing compound|
|regulation of cell death|
|tissue development|
|positive regulation of macromolecule biosynthetic process|
|positive regulation of cellular biosynthetic process|
|positive regulation of biosynthetic process|
\\
=== CRISPR Data ===
No hits were found.
No correlation found to any other genes in chemogenomics.
Global Fraction of Cell Lines Where Essential: 0/739
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/28|
|bone|0/26|
|breast|0/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|0/16|
|kidney|0/21|
|liver|0/20|
|lung|0/75|
|lymphocyte|0/16|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/9|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 12867
* **Expression level (log2 read counts)**: 7.21
{{:chemogenomics:nalm6 dist.png?nolink |}}